Company
Headquarters: Taipei, Taiwan
Employees: 76
TW$2.36 Billion
TWD as of July 1, 2024
US$72.5 Million
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
TSH Biopharm Corporation Limited develops and markets medicines for chronic diseases in Taiwan. It offers products for cardiovascular, central nervous, gastrointestinal, and others, as well as liquid-biopsy diagnosis. The company is headquartered in Taipei city, Taiwan. TSH Biopharm Corporation Limited is a subsidiary of TTY Biopharm Company Limited.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
TSH Biopharm Corp Ltd has the following listings and related stock indices.
Stock: TWSE: 8432 wb_incandescent